Literature DB >> 844667

Smith-Lemli-Opitz syndrome: neuropathological and ophthalmological observations.

M Fierro, A J Martinez, J W Harbison, S H Hay.   

Abstract

The case of a three-year-old boy with the Smith-Lemli-Opitz syndrome is reported. In addition to the constellation of skeletal and genital anomalies classically described in this syndrome, this patient had spontaneous opsoclonus-like eye movements, strabismus, lack of visual following responses and of opticokinetic reflexes. At autopsy the cerebellar vermis was found to be absent. There were retinal hemangiomas. Microscopical examinations showed loss of Purkinje cells and extensive neuronal degeneration within dentate nuclei, associated with patchy demyelination of cerebellar peduncles and central white matter. These findings may contribute to the explanation of the pathophysiology of opsoclonus and some of the neuro-ophthalmological findings.

Entities:  

Mesh:

Year:  1977        PMID: 844667     DOI: 10.1111/j.1469-8749.1977.tb08021.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  12 in total

Review 1.  The role of cholesterol in rod outer segment membranes.

Authors:  Arlene D Albert; Kathleen Boesze-Battaglia
Journal:  Prog Lipid Res       Date:  2005-03-09       Impact factor: 16.195

2.  7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.

Authors:  Libin Xu; Lowell G Sheflin; Ned A Porter; Steven J Fliesler
Journal:  Biochim Biophys Acta       Date:  2012-03-09

Review 3.  Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes.

Authors:  Timothy J Edwards; Elliott H Sherr; A James Barkovich; Linda J Richards
Journal:  Brain       Date:  2014-01-28       Impact factor: 13.501

Review 4.  The Smith-Lemli-Opitz syndrome.

Authors:  R I Kelley; R C Hennekam
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

5.  The Smith-Lemli-Opitz syndrome. A detailed pathological study as a clue to a etiological heterogeneity.

Authors:  E D Cherstvoy; G I Lazjuk; T I Ostrovskaya; I A Shved; G I Kravtzova; I W Lurie; A I Gerasimovich
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

6.  MRI in Smith-Lemli-Opitz syndrome type I.

Authors:  G Trasimeni; C Di Biasi; M Iannilli; L Orlandi; B Boscherini; R Balducci; G F Gualdi
Journal:  Childs Nerv Syst       Date:  1997-01       Impact factor: 1.475

Review 7.  Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models.

Authors:  Roman Chrast; Gesine Saher; Klaus-Armin Nave; Mark H G Verheijen
Journal:  J Lipid Res       Date:  2010-11-09       Impact factor: 5.922

8.  Smith-Lemli-Opitz syndrome type II: report of a case with additional radiographic findings.

Authors:  T E Herman; M J Siegel; B C Lee; S B Dowton
Journal:  Pediatr Radiol       Date:  1993

9.  Brain magnetic resonance imaging findings in Smith-Lemli-Opitz syndrome.

Authors:  Ryan W Y Lee; Sandra K Conley; Andrea Gropman; Forbes D Porter; Eva H Baker
Journal:  Am J Med Genet A       Date:  2013-08-05       Impact factor: 2.802

10.  Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features.

Authors:  Steven J Fliesler; Neal S Peachey; Michael J Richards; Barbara A Nagel; Dana K Vaughan
Journal:  Arch Ophthalmol       Date:  2004-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.